MARKET

MRVI

MRVI

Maravai Lifesciences Holdings, Inc.
NASDAQ
4.370
-0.290
-6.22%
Closed 19:33 05/13 EDT
OPEN
4.660
PREV CLOSE
4.660
HIGH
4.750
LOW
4.340
VOLUME
2.14M
TURNOVER
--
52 WEEK HIGH
4.995
52 WEEK LOW
1.950
MARKET CAP
1.13B
P/E (TTM)
-6.0484
1D
5D
1M
3M
1Y
5Y
1D
Maravai LifeSciences Q1 Turnaround Spurs Rethink Of CleanCap Driven Outlook
Simply Wall St · 4h ago
Analysts Offer Insights on Healthcare Companies: Astrana Health (ASTH) and Maravai Lifesciences Holdings (MRVI)
TipRanks · 2d ago
Maravai Lifesciences Signals Turnaround in Earnings Call
TipRanks · 2d ago
Analysts Offer Insights on Healthcare Companies: Harmony Biosciences Holdings (HRMY), Maravai Lifesciences Holdings (MRVI) and Alkermes (ALKS)
TipRanks · 2d ago
Weekly Report: what happened at MRVI last week (0504-0508)?
Weekly Report · 3d ago
Maravai (MRVI) Q1 2026 Earnings Transcript
The Motley Fool · 4d ago
Maravai LifeSciences Holdings (MRVI) EPS Loss Deepens Narrative On Persistent Profitability Concerns
Simply Wall St · 5d ago
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga · 5d ago
More
About MRVI
Maravai LifeSciences Holdings, Inc. is a life sciences company providing critical products to enable the development of drug therapies, diagnostics and novel vaccines and to support research on human diseases. Its segments include Nucleic Acid Production Segment and Biologics Safety Testing Segment. The Nucleic Acid Production segment is focused on the manufacturing and sale of highly modified nucleic acids products to support the needs of customers’ research, therapeutic and vaccine programs. This segment’s business units include TriLink Discovery, TriLink GMP, Glen Research and Alphazyme. The Biologics Safety Testing segment is focused on manufacturing and selling biologics safety and impurity tests and assay development services that are utilized by its customers in their biologic drug manufacturing activities. This segment’s business is comprised of Cygnus Technologies. It serves various companies, including biopharmaceutical, vaccine, diagnostics and cell and gene therapy.

Webull offers Maravai Lifesciences Holdings Inc stock information, including NASDAQ: MRVI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MRVI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MRVI stock methods without spending real money on the virtual paper trading platform.